ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BCLI Brainstorm Cell Therapeutics Inc

0.3456
-0.0214 (-5.83%)
Mar 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 194,738
Bid Price 0.3455
Ask Price 0.37
News -
Day High 0.365899

Low
0.134

52 Week Range

High
3.46

Day Low 0.3425
Company Name Stock Ticker Symbol Market Type
Brainstorm Cell Therapeutics Inc BCLI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0214 -5.83% 0.3456 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.355 0.3425 0.365899 0.3452 0.367
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
565 194,738 $ 0.3521807 $ 68,583 - 0.134 - 3.46
Last Trade Time Type Quantity Stock Price Currency
19:55:26 12 $ 0.3544 USD

Brainstorm Cell Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 48.98M - 0 -24.28M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Brainstorm Cell Therapeu... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BCLI Message Board. Create One! See More Posts on BCLI Message Board See More Message Board Posts

Historical BCLI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.360.38280.310.36130771,142,275-0.0144-4.00%
1 Month0.3850.410.300.3644568816,123-0.0394-10.23%
3 Months0.2220.41960.1640.27504411,582,6040.123655.68%
6 Months1.711.790.1340.26745632,352,172-1.36-79.79%
1 Year2.233.460.1340.50288791,316,525-1.88-84.50%
3 Years4.204.750.1341.36617,437-3.85-91.77%
5 Years3.9517.950.1343.61582,669-3.60-91.25%

Brainstorm Cell Therapeu... Description

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Your Recent History

Delayed Upgrade Clock